close

Enter

Log in using OpenID

Animal Health Active Pharmaceutical Ingredients Market Research Report 2017-2025

embed
Animal Health APIs Market | Favorable policies offered by these governments have been shifting the focus of API manufacturers in moving their production bases to APAC countries, such as India and China. In addition, limited insurance or government i
Global Market Study
on Animal Health
Active
Pharmaceutical Ingredients: Antiparasitics Segment by API Type to
Register a CAGR of 7.6% During 2017-2025
The global animal health active pharmaceutical ingredient (API) market is
expected to register an impressive expansion at 7.3% CAGR during the forecast
period 2017-2025. According to recent study by Persistence Market Research
(PMR), it is estimated that, the revenues from animal health API market are
expected to reach worth US$ 9,162.2 Mn by 2025-end.
Limited Government Intervention Provides Smooth Flow to the Market
Growth in APAC
Asia-Pacific (APAC) will be the most lucrative region in the global animal
health active pharmaceutical market, and is expected to exhibit higher CAGR
by 2025-end. APAC region has been identified for housing some of the largest
suppliers of affordable API. To save on the production costs, the concerned
governments have been taking initiatives to compel small scale API
manufacturers towards shifting their production units to APAC countries such
as India and China. Limited intervention of government facilitates smoother
flow of market growth in these countries.
However, according to western health regulatory agencies, API imported by
APAC manufactures doesn’t meet the required specification criteria set by ICH
(International Conference on Harmonization). There are concerns related to the
quality, safety and efficacy of such APIs.
Browse Full Research Report:
https://www.persistencemarketresearch.com/market-research/animal-healthactive-pharmaceutical-ingredients-market.asp
Western regulatory agencies are taking stringent actions on the APIs produced
in these region. The companies engaged in production are facing challenges
while bridging the gap between cost and the quality of APIs. Strict validations
and guidelines set by regulatory agencies are expected to hamper the growth of
API market in APAC region.
Europe to Remain the Second Largest Market for Animal Health APIs
Europe is expected to remain the second largest market for animal health active
pharmaceutical ingredients. Most of the leading healthcare companies operating
through Europe continuously require bulk amount of animal grade APIs. In
addition, consumption of animal grade API has increased substantially over the
past few years. Spain is one of the largest consumer of animal-grade
antimicrobial APIs in Europe.
APIs can facilitate productivity enhancement, which is of significant value to
the animal healthcare industry. Such factors are expected to augment the growth
of animal health API market in EU. Stringent approval process implemented by
the European Medicinal Agency (EMA) only permits registered APIs for their
use in production of pharmaceuticals. This is likely to result shortage of
intermediates and materials. The stringent guidelines as well as fragmented
market are likely to curb the market growth of animal grade API in Europe.
Request and Download Sample [email protected]
https://www.persistencemarketresearch.com/samples/16972
Antiparasitics to Remain in Large Demand in the Market
• Anti-parasitics expected to be the largely adopted active pharmaceutical
ingredient in the market
• Frequent bacterial infection to pets demands Anti-infective, which in turn
projected to account for the largest revenue by 2025-end
• Revenues from the sale of anesthetics and NSIDs will remain same as
compared to the collective revenues of anti-parasitics and anti-infectives
Key market players profiled in PMR’s report include Glenmark Pharmaceutical
Limited., Zoetis, Inc., Eli Lilly & Co., Sanofi Winthrop Industrie (CEPiA),
Indukern, S.A., Ofichem BV, P&R S.p.A (Olon S.p.A), Lonza Group AG,
Huvepharma AD, Ourofino Saude Animal, Blanver Farmoquimica E
Farmaceutica S.A., Zhejiang Hisun Pharmaceutical Co., Ltd, Changzhou
Yabang-Qh Pharmachem Co., Ltd., Shanghai Pharmtech Co., Ltd., Ningxia
Tairui Pharmaceutical Co., Ltd., Shaanxi Hanjiang Pharmaceutical Group Co.,
Ltd., Sequent Scientific Ltd., NGL Fine-Chem Ltd., Omkar Speciality
Chemicals Ltd., and Excel Industries Ltd.
Buy Full Eye Animal Health Active Pharmaceutical Ingredients Market
Report
@ https://www.persistencemarketresearch.com/checkout/16972
About Us
Persistence Market Research (PMR) is a third-platform research firm. Our
research model is a unique collaboration of data analytics and market research
methodology to help businesses achieve optimal performance.
To support companies in overcoming complex business challenges, we follow a
multi-disciplinary approach. At PMR, we unite various data streams from
multi-dimensional sources. By deploying real-time data collection, big data, and
customer experience analytics, we deliver business intelligence for
organizations of all sizes.
Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: [email protected]
Web: http://www.persistencemarketresearch.com
Author
shreyas.d
shreyas.d70   documents Email
Document
Category
Health and Medicine
Views
5
File Size
324 KB
Tags
active
1/--pages
Report inappropriate content